Proteomics

Dataset Information

0

The NFIB/CARM1 Partnership is a Therapeutic Target for Small Cell Lung Cancer


ABSTRACT: This project identified NFI family members as CARM1 substrates. NFIB was previously reported to play a critical role in the development of small cell lung cancer. We provided evidence that the arginine methylation of NFIB is required for its oncogenic function in small cell lung cancer.

INSTRUMENT(S): Orbitrap Fusion ETD

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Bill Russell  

PROVIDER: MSV000090746 | MassIVE | Sat Nov 19 07:31:00 GMT 2022

SECONDARY ACCESSION(S): PXD038217

REPOSITORIES: MassIVE

Similar Datasets

| S-EPMC6219836 | BioStudies
| S-EPMC4701905 | BioStudies
| S-EPMC4451140 | BioStudies
| S-EPMC5555576 | BioStudies
| S-EPMC5797028 | BioStudies
| S-EPMC7827394 | BioStudies
| S-EPMC4741501 | BioStudies
| S-EPMC7574240 | BioStudies
| S-EPMC4063255 | BioStudies
| S-EPMC6039709 | BioStudies